NeuroNascent, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2004-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.neuronascent.com
Phase1a, Dose-escalation Study of NNI-362 in Healthy Aged Volunteers
- First Posted Date
- 2019-08-30
- Last Posted Date
- 2023-02-17
- Lead Sponsor
- Neuronascent, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT04074837
- Locations
- 🇺🇸
Parexel, International, Glendale, California, United States
© Copyright 2025. All Rights Reserved by MedPath